Integrated Safety and Efficacy Analysis of FMX103 1.5% Topical Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea: Results From Two Phase 3 Studies. J of Skin [Internet]. 2020 Sep. 2 [cited 2025 Apr. 18];4(5):s55. Available from: https://skin.dermsquared.com/skin/article/view/1000